Healthcare professionals

AfA is here to help you care for and manage patients living with HIV/AIDS. Access our team of clinical HIV experts to get support, ask for advice and discuss complex clinical challenges. Explore our protocols, guidelines, publications and clinical intelligence.


CPD online training

Gain HIV management skills.

Online modular training for doctors and other healthcare professionals in HIV medicine offers a practical solution to gain HIV management skills. It is particularly suitable for those working outside of the major centres.

You can complete individual modules or the full training programme.

  • The modules cover the basics of HIV management and reflect current best practice, both nationally and internationally.
  • Each module is CPD-accredited with a CPD certificate issued online following successful answering of several multiple-choice questions.
  • All the modules will be updated annually.
  • There will be a dedicated annual HIV update module based on new guidelines and advances in HIV management.

Registration on the course is free of charge and is open to all doctors as well as other interested healthcare professionals.

Please go here to register, using your professional council registration number, and follow the simple instructions. If you do not have a professional council number your ID number may be used.

The course has been developed by Professor Gary Maartens, who is an acknowledged expert in HIV management and has participated in the development of HIV treatment guidelines both nationally and internationally. He has been involved in teaching and research in HIV medicine for many years and has been a senior consultant on the AfA Clinical Advisory Committee since its inception in 1998.

Publications and Presentations

AfA has spoken at and participated in local and international conferences, had its collaborative research published and been invited to speak at a variety of organisations. Our approach is to share our expertise on the clinical, programmatic and behavioural aspects of managing HIV in different settings freely.


February 2016

  • Do elite controllers need ART?
  • Early infant diagnosis of HIV – shifting paradigms
  • Lifelong ART should be offered to ALL HIV-infected patients regardless of CD4 count
  • Pneumococcal vaccination in HIV-infected persons

September 2015

  • Probiotics and HIV
  • Improved treatment outcomes in patients with XDR TB in South Africa
  • HIV tests in children on ART
  • Management of hyperlipidaemia in patients on protease inhibitors
  • Cross-reactivity between Darunavir and Co-trimoxazole
  • New 0199 tariff claiming process

July 2015

  • Rilpivirine (RPV) in pregnancy
  • Is there a need for 6-monthly CD4 monitoring in patients with stable virological suppression on ART?
  • Twitter for the busy clinician – opening up a world of HIV-related information
  • The role of micronutrient supplementation in adults

March 2015

  • HIV-positive-to-HIV-positive renal transplantation
  • Pre-exposure prophylaxis (PrEP): recent findings add to the evidence that it is effective as an HIV prevention tool
  • Use of Raltegravir in children
  • Balancing risks and benefits in post exposure prophylaxis

November 2014

  • Abacavir-based regimens in patients with high viral loads
  • Proton pump inhibitor, H2 receptor blocker and antacid drug interactions with Atazanavir/Ritonavir
  • Update on the Mississippi child – a reality check
  • Maraviroc
  • A festive reflection

August 2014

  • The EARNEST trial: new evidence regarding efficacy of second line ART regimens
  • New drug profile: Rilpivirine
  • The value of a psychological report in treatment failure
  • Clinical case report – 35-year-old male patient on a PMB medical scheme option (subject to state protocols)

December 2013

  • Key principles in the management of patients with suspected drug-induced liver injury (DILI) while on TB treatment (with or without ART)
  • The perinatally infected adolescent
  • Rifabutin in HIV medicine
  • Should one discontinue Co-trimoxazole prophylaxis in children established on ART?

August 2013

  • Fixed dose combination antiretrovirals containing TDF, FTC/3TC and Efavirenz
  • Combination induction therapy for cryptococcal meningitis
  • Isoniazid preventive therapy for people on ART
  • An approach to weight loss in HIV-infected patients
  • World Health Organisation raises the bar

April 2013

  • Etravirine
  • Potential Cure of HIV in an infant – the Mississippi child – what can we learn? Can we already change our practice?
  • Use of pre-exposure prophylaxis
  • 20th Conference on retroviruses and opportunistic Infections

December 2012

  • Practice point –  ‘lipodystrophy’ due to an unexpected drug interaction
  • Timing of ART in patients with cryptococcal meningitis
  • Abacavir or Tenofovir in 1st line ART?
  • A festive reflection

June 2012

  • National Department of Health guidelines on the management of drug-resistant TB
  • Study of switching to atazanavir for lipodystophy
  • Reporting adverse drug reactions
  • Tenofovir for children and adolescents

February 2012

  • The conundrum of infant feeding for HIV-infected women continues
  • Tenofovir and aminoglycosides
  • What if my patient’s CD4 count does not rise on ART
  • Isoniazid preventive therapy